10月21日,Collegium Pharmaceutical(COLL)收涨0.96%,报23.23美元,成交额1247.04万美元,市值7.56亿美元。 公司最新财报显示,季度营收2亿美元,同比增长6.32%;净亏损1505.1万美元,上年同期净利润1198.3万美元。 公司简介 该公司已开发、许可并收购了一系列用于治疗注意力缺陷多动障碍(ADHD)和中度至重度疼痛的产品。其商业产品包括在美国 ...
10月20日,Collegium Pharmaceutical(COLL)收跌0.78%,报23.01美元,成交额1654.82万美元,市值7.49亿美元。行情数据• 开盘价:22.99美元• 最高价:23.54美元• 最低价:22.74美元• 成交量:71.
Collegium Pharmaceutical is rated a Buy after a guidance cut and stock drop, with the market pricing in an overly pessimistic ...
Tupper stated, "We are updating our 2026 financial guidance primarily to reflect lower-than-expected full-year revenue for the NUCYNTA franchise due to lower net pricing for the authorized generics," ...
本研究旨在评估与比较无近期阿片使用障碍(opioid use disorder, OUD)阳性史的慢性腰痛(chronic low back pain, cLBP)患者使用不同阿片类药物的安全性特征。研究人员采用Merative MarketScan?数据库( 本 ...
Case Name: BioDelivery Sciences Int’l, Inc. v. Alvogen PB Research & Development LLC, Civ. No. 18-1395-CFC, 2026 WL 84392 (D. Del. Jan. 12, 2026) (Connolly, J ...
Collegium Pharmaceutical’s pain management portfolio, including Xtampza ER and Belbuca, drives 92.8% of revenues, demonstrating its market leadership in abuse-deterrent therapies. The acquisition of ...
The favorite day of stoners across the globe is upon us: April 20 or 4/20, also known as weed day, is this Saturday. Coincidentally falling on the same weekend as National Cold Brew Day and National ...
Tecno's latest Spark 20 Pro+ is the culmination of the Spark 20 series and features everything the maker can offer in this price range without breaking the bank. And while the Spark 20 Pro+ is no ...
If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. ABC’s news program 20/20 is now in its 46th season, ...
Collegium said it is on track to grow revenue over 20% and adjusted EBITDA over 35% in 2023. Collegium expects to deliver top- and bottom-line growth in 2024. Get the data-driven signals to profit ...
For years I had a negative impression of buprenorphine as a pain medication, both from personal descriptions I had heard by pain patients and from the scientific and medical literature. I have since ...